EventsAntibiotics 2026—Advances in Antimicrobial Action and Resistance
Published
This submission belongs to the session S2. Antimicrobials, Antimicrobial Resistance, and One Health of the event Antibiotics 2026—Advances in Antimicrobial Action and Resistance
Published date
04 May, 2026
Academic Editor
author-avatarManuel Simões
Citation
Luísa Peixe, Are We Measuring or Controlling AMR? Carbapenemases as a One Health Sentinel from Food Systems to Environmental Policy, in Proceedings of Antibiotics 2026—Advances in Antimicrobial Action and Resistance, Barcelona, 11 May–14 May 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Are We Measuring or Controlling AMR? Carbapenemases as a One Health Sentinel from Food Systems to Environmental Policy

1. Applied Molecular Biosciences Unit (UCIBIO), Faculty of Pharmacy of the University of Porto (FFUP), Portugal, Portugal
Abstract

Antimicrobial resistance (AMR) is driven by the global dissemination of carbapenemase-producing Enterobacterales, compromising last-resort antibiotics and challenging clinical management. Within a One Health framework, carbapenemases represent key molecular markers to investigate transmission dynamics across human, animal, food, and environmental compartments. This presentation integrates current evidence on the occurrence and spread of carbapenemase producers along the food chain, including food-producing animals, retail products, and processing environments. Mechanistic insights into persistence and dissemination remain limited but may involve biofilm formation and horizontal gene transfer. Despite advances in surveillance, critical limitations remain, including inconsistent detection methodologies, underrepresentation of specific resistance mechanisms, and insufficient integration of genomic data for source attribution. Recent environmental monitoring initiatives expand surveillance capacity but frequently lack defined thresholds for intervention and translational pathways to control. By focusing on carbapenemases, this talk evaluates the extent to which current surveillance frameworks inform effective mitigation strategies, emphasizing the need for integrated, risk-based approaches with clear translational impact across the One Health continuum.

Keywords
One Health
Carbapenemases
AMR
Oral Presentation
Emerging Antibiotic Resistances Worldwide
Silencing bacterial communication with lactic acid bacteria metabolites: an eco-friendly approach against foodborne pathogenic biofilms